Omalizumab: Clinical Use for the Management of Asthma

Abstract

Omalizumab, a humanized monoclonal antibody that binds circulating IgE antibody, is a treatment option for patients with moderate to severe allergic asthma whose asthma is poorly controlled with inhaled corticosteroids and inhaled long-acting β(2) agonist bronchodilators. This review considers the mechanism of action, pharmacokinetics, efficacy, safety and… (More)
DOI: 10.4137/CCRPM.S7793

Topics

3 Figures and Tables

Cite this paper

@inproceedings{Thomson2012OmalizumabCU, title={Omalizumab: Clinical Use for the Management of Asthma}, author={Neil C Thomson and Rekha Chaudhuri}, booktitle={Clinical medicine insights. Circulatory, respiratory and pulmonary medicine}, year={2012} }